Quantcast
Channel: cafepharma - BMS-791325
Browsing all 5 articles
Browse latest View live

Bristol-Myers Hepatitis C Combo Therapy Shows Promise

Bristol-Myers Hepatitis C Combo Therapy Shows Promise Bloomberg

View Article


Bristol-Myers Hepatitis C Combo Therapy Blunts Disease

Bristol-Myers Hepatitis C Combo Therapy Blunts Disease Bloomberg

View Article


Bristol Still Playing Catch-Up To Gilead In Hep C Drug Race

Bristol Still Playing Catch-Up To Gilead In Hep C Drug Race TheStreet.com

View Article

Three Future Winners and One Major Loser in the HCV Wars

Three Future Winners and One Major Loser in the HCV Wars Motley Fool

View Article

3 Companies Racing to Transform Hepatitis-C Treatment

3 Companies Racing to Transform Hepatitis-C Treatment Motley Fool

View Article

Browsing all 5 articles
Browse latest View live